Literature DB >> 6221272

[Monotherapy with clobazam in epilepsies in children].

O Dulac, D Figueroa, E Rey, M Arthuis.   

Abstract

Twenty-five epileptic children were treated with clobazam alone for periods of 10 days to 36 months (mean = 9 months and 16 months for children who responded well). Satisfactory results were obtained in 11 patients and marked improvement with a 75% decrease in the initial frequency of seizures in 6 patients. The seizures recurred after a few weeks in 3 other patients. This preliminary study shows that clobazam is well tolerated and remarkably effective, especially in benign partial epilepsy, even in carbamazepine-resistant cases.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6221272

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  4 in total

1.  Diagnosing idiopathic/cryptogenic epilepsy syndromes in infancy.

Authors:  N Sarisjulis; B Gamboni; P Plouin; A Kaminska; O Dulac
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

Review 2.  Clobazam.

Authors:  Yu-tze Ng; Stephen D Collins
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

3.  Clobazam in the treatment of epilepsy: prospective follow-up to 8 years.

Authors:  N Buchanan
Journal:  J R Soc Med       Date:  1993-07       Impact factor: 5.344

4.  Effect of clobazam as add-on antiepileptic drug in patients with epilepsy.

Authors:  Rupa Joshi; Manjari Tripathi; Pooja Gupta; Yogendra Kumar Gupta
Journal:  Indian J Med Res       Date:  2014-08       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.